Where does Suzhou Alphamab Co., Ltd. rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Suzhou Alphamab Co., Ltd. ranks #33,485 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Suzhou Alphamab Co., Ltd. hold?

Suzhou Alphamab Co., Ltd. holds 8 US utility patents granted between 2017 and 2025, spanning 8 technology areas.

What is Suzhou Alphamab Co., Ltd.'s Innovation Score?

Suzhou Alphamab Co., Ltd. has an Innovation Score of 34.9 out of 100 (49th percentile of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does Suzhou Alphamab Co., Ltd. focus on?

Suzhou Alphamab Co., Ltd.'s top technology area is C07K (Peptides) with 8 patents. Grants appear in 8 CPC subclasses total.

Is Suzhou Alphamab Co., Ltd.'s patent grant rate increasing or decreasing?

Suzhou Alphamab Co., Ltd.'s recent grant velocity is +150% compared to the prior five-year period (grant years, not application filing dates). This indicates accelerating grant output.

What does claim depth mean for Suzhou Alphamab Co., Ltd.'s patents?

Suzhou Alphamab Co., Ltd.'s patents average 12.1 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Suzhou Alphamab Co., Ltd. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Suzhou Alphamab Co., Ltd.

USPTO PatentsView assignee record - 8 granted patents across 8 technology areas, recorded in grant years 2017–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: C07K (Peptides).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Suzhou ranks #33,485 of 49,997 tracked US assignees by granted-patent volume, with 8 patents across 8 technology areas.

#33,485
of 49,997 US assignees by volume: 49th percentile
by Innovation Score (34.9/100): 12.1
avg claims per patent: +150%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R33485 · Foreign Corporation #33,485 · 8 grants

GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-RICH · TYPE-FRNCORP · VEL-SURGE · BOOK-FULL

GRANTS-MICRO 8 grants
MID-PACK #33,485/49,997
PHOTO-FINISH Sunoco Partners…
CPC-NARROW C07K · 8 areas
INNOV-THIN 34.9/100
CLAIMS-RICH 12.1 claims/avg
TYPE-FRNCORP Foreign Corp
VEL-SURGE +150% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Sunoco Partners Marketing & Terminals L.P. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

Qualcomm Incorporated · highest

85
Suzhou Alphamab · this assignee

35
3D Lighting… · lowest

7

What this shows Suzhou's Innovation Score is 34.9/100 (49th percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Where Suzhou's grants concentrate

Suzhou Alphamab Co., Ltd. is a focused PatentsView assignee: 8 CPC subclasses with 100% of grants classified under C07K (Peptides). Peak complete grant year is 2021 (2 grants) versus a trough of 1 in 2017. By volume, Suzhou sits between Sunoco Partners Marketing & Terminals L.P. and Swallow Incubate Co., Ltd.

Suzhou's three-year grant acceleration

Suzhou Alphamab Co., Ltd. shows 3 grants in 2022–2024 against only 2 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Sunoco Partners M…

8
Sunrise Wholesale

8
Sunsea Telecommun…

8
Suppremol

8
Suzhou Neupharma

8
Suzhou Singmed Me…

8
Svolt Energy Tech…

8
Swallow Incubate

8
Suzhou Alphamab ◀

8

What this shows Suzhou holds 8 patents at rank #33,292, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Suzhou

By rank, the assignees closest to #33,292 in granted patent volume.

Leaders in C07K (Peptides)

Other assignees with the most granted patents in Suzhou's primary technology class.

Suzhou's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

35 49th percentile higher than 49% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2017–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2017–2019 baseline. Full figures in the table below.

View data table

Suzhou Alphamab Co., Ltd. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2017	1	12.5%
2018	1	12.5%
2021	2	25.0%
2022	2	25.0%
2024	1	12.5%
2025partial year	1	12.5%

Which technologies does Suzhou Alphamab Co., Ltd. patent most?

C07K - Peptides 8

A61K - Preparations FOR Medical, Dental OR Toiletry Purposes 8

C12N - Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media 6

A61P - Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations 5

C12P - Fermentation OR Enzyme-using Processes TO Synthesise A Desired Chemical Compound OR Composition OR TO Separate Optical Isomers From A Racemic Mixture 3

Y02A - Technologies FOR Adaptation TO Climate Change 2

G01N - Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties 2

A61N - ELECTROTHERAPY; MAGNETOTHERAPY; Radiation THERAPY; Ultrasound Therapy 1

Top 8 of 8 technology areas

Where it ranks

Overall rank by patents

#33,485

of 49,997 tracked assignees

Innovation Score

34.9 out of 100

View all rankings →

Data Source

USPTO PatentsView, US granted patents 2015–2025

How is Innovation Score calculated?

What to do with this data

Suzhou Alphamab Co., Ltd.'s patent record in context - here's where to go next.

Suzhou Alphamab Co., Ltd.'s lead technology class is C07K (Peptides), 100% of its portfolio - see every assignee active in that class. Explore C07K
Ranked #33,485 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Suzhou Alphamab Co., Ltd. against Sunoco Partners Marketing & Terminals L.P., an assignee filing at a similar volume. Compare portfolios
Innovation Score of 34.9/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.